FDA Inspection 1025893 — Lisa N. Boggio, MD
The FDA completed an inspection of Lisa N. Boggio, MD on May 22, 2017 in Chicago, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- May 22, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Chicago, IL (United States)
Additional details
Clinical Investigator (CI)